AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese Population

Nagoya Daini Red Cross Hospital, Nagoya

Fujita Health University, Toyoake-shi

ShinTokyo, Matsudo-shi

Kokura Memorial Hospital, Kitakyushu-shi

Kurume University, Kurume-shi

Shinkoga Hospital, Kurume-shi

Hanaoka Seishu Memorial Cardiovascular Clinic, Sapporo

Kyoto University, Kyoto

Kansairosai Hospital, Amagasaki-shi

Kobe University, Kobe

Tsukuba Medical Center, Tsukuba

Iwate Medical University, Morioka

Tokai University, Isehara-shi

Shonankamakura General Hospital, Kamakura-shi

Kanto Rosai Hospital, Kawasaki-shi

Saiseikai Yokohamashi Tobu Hospital, Yokohama

Saiseikai Kumamoto Hospital, Kumamoto

Miyazak Medical Association Hospital, Miyazaki

Tenri Hospital, Tenri-shi

Kurashiki Central Hospital, Kurashiki-shi

Sakurabashi Watanabe Hospital, Osaka

Osaka University, Suita-shi

The National Cerebral and Cardiovascular Center, Suita-shi

Saitama Medical Center Jichi Medical University, Saitama-shi

Saitama Sekishinkai, Sayama-shi

Juntendo University, Bunkyo-ku

University of Tokyo, Bunkyo-ku

Mitsui Memorial Museum, Chiyoda-ku

Sakakibara Memorial Hospital, Fuchu-shi

Teikyo University, Itabashi-Ku

Toho University Ohashi Medical Center, Meguro-ku

The Cardiovascular Institute Hospital, Minato-Ku

Showa University Hospital, Shinagawa-ku

Tokyo Women's Medical University, Shinjuku-ku

Dokkyo University, Tochigi

Wakayama Medical University Hospital, Kimiidera

Yamaguchi University, Ube-shi

Tokushima Red Cross Hospital, Tokushima

Abbott Vascular Japan Co., Ltd., Tokyo